Recommendations Issued for CT Contrast Use in Kidney Disease
Experts say risk overstated for use of IV iodinated contrast media in patients with reduced renal function.
Contrast Nephropathy
CONTRAST NEPHROPATHY
Hepcidin May Enable Early Ruling Out of Contrast-Induced AKI
Serum hepcidin rises significantly as early as 4 and 8 hours after percutaneous coronary intervention.
Gadolinium-Based Contrast May Up Acute Kidney Injury Risk in CKD
The risk of post-contrast acute kidney injury increased with decreasing renal function.
Ultra-low Contrast Volume May Protect Kidneys in Advanced CKD
No patient had a 25% or greater rise in serum creatinine 48 hours after receiving a median 13 mL of contrast for diagnostic coronary angiography, with an additional 13 mL for percutaneous coronary intervention.
Nicorandil May Prevent Contrast-induced Nephropathy
Nicorandil significantly reduced contrast-induced nephropathy by 62%, compared with controls.
IV Sodium Bicarbonate Does Not Reduce AKI Risk After Angiography
Contrast-associated acute kidney injury occurred in 9.5% and 9.1% of patients receiving IV sodium bicarbonate and acetylcysteine, respectively, rates which did not differ significantly from the 8.3% rate among those receiving IV sodium chloride.
AKI More Likely After Intracoronary Versus IV Contrast Delivery
In a phase 3 trial, acute kidney injury developed in 13.2% of patients undergoing invasive coronary angiography compared with 5.6% of those undergoing computed tomography angiography.
AKI After Computed Tomography Not Tied to Contrast
AKI occurred with similar frequency among patients who did and did not receive contrast medium.
Risk Factors for Contrast-Induced AKI in Transplant Patients ID’d
Risk factors include impaired renal function and inadequate hydration prior to contrast exposure.
Study Questions Prophylactic Hydration as Standard Care for CIN
High-risk patients who did not receive guidelines-recommended prophylactic hydration prior to procedures requiring iodinated contrast media had the same rate of contrast-induced nephropathy (CIN) as patients who received usual care, according to results from the phase 3 AMACING trial published online ahead of print in The Lancet.1 CIN refers to the decline in renal function…
Want to read more?
Please login or register first to view this content.
Next post in Acute Kidney Injury
